ArticleTheranostics2020
Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 43 citations in OpenAlex.
- Understanding the Epigenetic Landscape of Barrett's Esophagus and Esophageal Cancer: A Review of Current Findings, Caveats and Future Directions.Genes, chromosomes & cancer · 2026Review
- Advances in epigenetic therapy for esophageal cancer.Clinical epigenetics · 2026Review
- EV-derived miR-1246 promotes lymph node metastasis in esophageal squamous cell carcinoma through targeting the PPP2CB/NF-κB axis.Frontiers in immunology · 2026Article
- Analysis of the associations between DNA methylation and clinical features reveals the potential oncogenic effect of CFAP52 in esophageal squamous cell cancer.Cancer cell international · 2025Article
- Improved circulating tumor DNA identification for detection of esophageal squamous cell carcinoma by enzymatic methyl sequencing and hybrid neural network.Scientific reports · 2025Article
- Insight into the role of DNA methylation in prognosis and treatment response prediction of gastrointestinal cancers.Epigenomics · 2025Review
- Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity.Briefings in bioinformatics · 2025Article
- Habitat radiomics assists radiologists in accurately diagnosing lymph node metastasis of adenocarcinoma of the esophagogastric junction.Insights into imaging · 2025Article
- Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases.Functional & integrative genomics · 2025Review
- Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma.International journal of clinical oncology · 2025Article
- Benchmarking strategies for CNV calling from whole genome bisulfite data in humans.Computational and structural biotechnology journal · 2025Article
- Unlocking ESCC Progression: CCL15-CCR1 Axis Activates AKT/ERK1/2/c-Jun/CDK2 Pathway.Journal of Cancer · 2025Article
- Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.Nature communications · 2024Article
- RBM15 increase tumor-infiltrating CD4+ T cell in ESCCAmerican journal of cancer research · 2024Article
- Article
- circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.BMC cancer · 2023Article
- Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation.Genome biology · 2023Article
- TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750.Cell death discovery · 2023Article
- Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023Review
- Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.Computational and structural biotechnology journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 6 institutions in 1 country.
Huajing TengInstitute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
Meiying XueBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Jialong LiangBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Xingxing WangInstitute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
Lu WangBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Wenqing WeiBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Chao LiInstitute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
Ze ZhangInstitute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
Qinglan LiBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Xia RanBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Xiaohui ShiBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Wanshi CaiBeijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
Weihu WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Hengjun GaoInstitute of Digestive Diseases, Tongji University School of Medicine, Shanghai, China.
Zhongsheng SunInstitute of Genomic Medicine, Wenzhou Medical University, Wenzhou, China.
Chinese Academy of Sciences · CNUniversity of Chinese Academy of Sciences · CNWenzhou Medical University · CNPeking University · CNPeking University Cancer Hospital · CNShanghai Center For Bioinformation Technology · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
DNA MethylationGene Expression Regulation, NeoplasticCarcinoma, Squamous CellDisease ProgressionDNA, NeoplasmEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaGene DosageGenetic HeterogeneityHumansKaplan-Meier EstimateLymphatic MetastasisPrecision MedicinePrognosisTreatment OutcomeWhole Genome SequencingDNA, Neoplasmcancer mortalityepigenetic heterogeneitypersonalized medicineprognostic markerswhole-genome bisulfite sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.